More articles from Volume 39, Issue 2, 2025
Synchronous Gastrointestinal Stromal Tumor and Pancreatic Ductal Adenocarcinoma: A Rare Case Report With Clinical Implications and Molecular Overlaps
Efficacy and safety of bevacizumab in combination with chemotherapy in metastatic colorectal cancer — a single-center real-world analysis
Mild excess of serum basal calcitonin – a diagnostic challenge
Angiosome-oriented lower limb revascularization for the management of chronic ischemia and diabetic foot
Supportive Therapy in Esophageal Cancer
Article views
Synchronous Gastrointestinal Stromal Tumor and Pancreatic Ductal Adenocarcinoma: A Rare Case Report With Clinical Implications and Molecular Overlaps
Department of General Surgery, Clinical Hospital Center Zemun
Faculty of Medicine, University of Belgrade , Belgrade , Serbia
Department of General Surgery, Clinical Hospital Center Zemun
Oncology Hospital, Clinical Hospital Center Zemun
Department of Radiology, Clinical Hospital Center Zemun
Abstract
The synchronous occurrence of a gastrointestinal stromal tumor (GIST) and pancreatic ductal adenocarcinoma (PDAC) is exceptionally rare and poses significant diagnostic and therapeutic challenges. We report a 67-year-old female presenting with biliary obstruction, right upper quadrant pain, and dyspeptic symptoms. CT imaging revealed a pancreatic head mass, while a submucosal gastric lesion was identified only intraoperatively. Laparotomy enabled excision of a pedunculated gastric GIST, whereas the unresectable pancreatic tumor involved critical vascular structures, necessitating a palliative double bypass comprising cholecystectomy, hepaticojejunostomy, gastrojejunostomy, and enteroenterostomy. Histopathology confirmed a low-risk GIST and a moderately differentiated PDAC with distinct immunohistochemical profiles, supporting the presence of two independent primary tumors.
This case underscores the critical importance of meticulous intraoperative exploration, particularly in the presence of atypical or incidentally discovered lesions, and demonstrates the durable palliation afforded by surgical bypass in unresectable PDAC. Beyond the clinical context, potential molecular overlaps—activation of MAPK/ERK and PI3K/AKT/mTOR pathways, VEGF-mediated angiogenesis, and defects in DNA repair—provide a plausible biological basis for the synchronous occurrence of these otherwise unrelated neoplasms, informing potential strategies for personalized therapy
Keywords
References
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.